Lewis Kim, Lee Richard E, Brötz-Oesterhelt Heike, Hiller Sebastian, Rodnina Marina V, Schneider Tanja, Weingarth Markus, Wohlgemuth Ingo
Antimicrobial Discovery Center, Northeastern University, Boston, MA, USA.
Department of Chemical Biology and Therapeutics, St Jude Children's Research Hospital, Memphis, TN, USA.
Nature. 2024 Aug;632(8023):39-49. doi: 10.1038/s41586-024-07530-w. Epub 2024 Jul 31.
In this Review, we explore natural product antibiotics that do more than simply inhibit an active site of an essential enzyme. We review these compounds to provide inspiration for the design of much-needed new antibacterial agents, and examine the complex mechanisms that have evolved to effectively target bacteria, including covalent binders, inhibitors of resistance, compounds that utilize self-promoted entry, those that evade resistance, prodrugs, target corrupters, inhibitors of 'undruggable' targets, compounds that form supramolecular complexes, and selective membrane-acting agents. These are exemplified by β-lactams that bind covalently to inhibit transpeptidases and β-lactamases, siderophore chimeras that hijack import mechanisms to smuggle antibiotics into the cell, compounds that are activated by bacterial enzymes to produce reactive molecules, and antibiotics such as aminoglycosides that corrupt, rather than merely inhibit, their targets. Some of these mechanisms are highly sophisticated, such as the preformed β-strands of darobactins that target the undruggable β-barrel chaperone BamA, or teixobactin, which binds to a precursor of peptidoglycan and then forms a supramolecular structure that damages the membrane, impeding the emergence of resistance. Many of the compounds exhibit more than one notable feature, such as resistance evasion and target corruption. Understanding the surprising complexity of the best antimicrobial compounds provides a roadmap for developing novel compounds to address the antimicrobial resistance crisis by mining for new natural products and inspiring us to design similarly sophisticated antibiotics.
在本综述中,我们探讨了不仅仅是简单抑制必需酶活性位点的天然产物抗生素。我们对这些化合物进行综述,为设计急需的新型抗菌剂提供灵感,并研究已进化出的有效靶向细菌的复杂机制,包括共价结合剂、抗性抑制剂、利用自我促进进入的化合物、逃避抗性的化合物、前药、靶点破坏剂、“不可成药”靶点的抑制剂、形成超分子复合物的化合物以及选择性膜作用剂。β-内酰胺共价结合以抑制转肽酶和β-内酰胺酶、铁载体嵌合体劫持导入机制将抗生素偷运进细胞、被细菌酶激活以产生活性分子的化合物以及诸如氨基糖苷类等破坏而非仅仅抑制其靶点的抗生素等均为例证。其中一些机制非常复杂,例如达洛巴汀预先形成的β链靶向不可成药的β桶形伴侣蛋白BamA,或者替加环素,它与肽聚糖的前体结合,然后形成破坏膜的超分子结构,阻碍抗性的出现。许多化合物表现出不止一个显著特征,如逃避抗性和破坏靶点。了解最佳抗菌化合物令人惊讶的复杂性为开发新型化合物提供了路线图,通过挖掘新的天然产物来应对抗菌药物耐药性危机,并激励我们设计同样复杂的抗生素。